{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T06:06:00Z","timestamp":1774418760866,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T00:00:00Z","timestamp":1761436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T00:00:00Z","timestamp":1761436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-025-04099-2","type":"journal-article","created":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:16:15Z","timestamp":1761462975000},"page":"1444-1450","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative analysis of risk prediction scores including all types of cancer-associated thrombosis"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3457-3091","authenticated-orcid":false,"given":"Irene Gonz\u00e1lez","family":"Caraballo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e1rbara Lobato","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena Ruiz","family":"Zamorano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Salgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Pach\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquina Mart\u00ednez","family":"Gal\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Castell\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itziar","family":"Gardeazabal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime Rubio","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio Garc\u00eda","family":"Escobar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaura","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Quintanar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carme","family":"Font","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier Soto","family":"Alsar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura Ortega","family":"Mor\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Manuel Soria","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s J. Mu\u00f1oz","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,26]]},"reference":[{"key":"4099_CR1","first-page":"188","volume":"1","author":"BS De","year":"1823","unstructured":"De BS. l\u2019obliteration des veines et de son influence sur la formation des hydropisies partielles: consideration sur la hydropisies passive et g\u00e9n\u00e9ral. Arch Gen Med. 1823;1:188\u2013204.","journal-title":"Arch Gen Med"},{"key":"4099_CR2","first-page":"654","volume-title":"Clinique m\u00e9dicale de l\u2019h\u00f4tel-dieu de paris","author":"A Trousseau","year":"1865","unstructured":"Trousseau A. Phlegmasia alba dolens. In: Clinique m\u00e9dicale de l\u2019h\u00f4tel-dieu de paris. 2nd ed. Paris: The Sydenham Society; 1865. p. 654\u2013712.","edition":"2"},{"issue":"1","key":"4099_CR3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41416-022-01968-3","volume":"15","author":"S Koizume","year":"2022","unstructured":"Koizume S, Miyagi Y. Tissue factor in cancer-associated thromboembolism. J Hematol Oncol. 2022;15(1):112. https:\/\/doi.org\/10.1038\/s41416-022-01968-3.","journal-title":"J Hematol Oncol"},{"issue":"9","key":"4099_CR4","first-page":"967","volume":"85","author":"G Grignani","year":"2000","unstructured":"Grignani G, Maiolo A. Cytokines and hemostasis. Haematologica. 2000;85(9):967\u201372.","journal-title":"Haematologica"},{"key":"4099_CR5","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1182\/bloodadvances.2021005590","volume":"6","author":"A Mahajan","year":"2022","unstructured":"Mahajan A, Brunson A, Adesina O, Keegan THM, Wun T. The incidence of cancer-associated thrombosis is increasing over time. Blood Adv. 2022;6:307\u201320. https:\/\/doi.org\/10.1182\/bloodadvances.2021005590.","journal-title":"Blood Adv"},{"issue":"4","key":"4099_CR6","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1001\/archinte.166.4.458","volume":"166","author":"HK Chew","year":"2006","unstructured":"Chew HK, Wun T, Harvey D, Zhou H, White RH. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med. 2006;166(4):458\u201364. https:\/\/doi.org\/10.1001\/archinte.166.4.458.","journal-title":"Arch Intern Med"},{"issue":"3","key":"4099_CR7","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374","volume":"5","author":"AA Khorana","year":"2007","unstructured":"Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost. 2007;5(3):632\u20134. https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02374.","journal-title":"J Thromb Haemost"},{"key":"4099_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2024.100900","volume":"53","author":"A Li","year":"2024","unstructured":"Li A, Zhou E. Trends and updates on the epidemiology of cancer-associated thrombosis. Blood Rev. 2024;53:100900. https:\/\/doi.org\/10.1016\/j.blre.2024.100900.","journal-title":"Blood Rev"},{"issue":"2","key":"4099_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10278-025-01552-0","volume":"38","author":"HR Troutt","year":"2025","unstructured":"Troutt HR, Huynh KN, Joshi A, Ling J, Refugio S, Cramer S, et al. Efficacy of an automated pulmonary embolism (PE) detection algorithm in non-dedicated contrast-enhanced CT chest imaging studies. J Digit Imaging. 2025;38(2):123\u201330. https:\/\/doi.org\/10.1007\/s10278-025-01552-0.","journal-title":"J Digit Imaging"},{"key":"4099_CR10","doi-asserted-by":"publisher","DOI":"10.1177\/1076029620954282","volume":"26","author":"MS Hamza","year":"2020","unstructured":"Hamza MS, Mousa SA. Cancer-associated thrombosis: risk factors, molecular mechanisms, future management. Clin Appl Thromb Hemost. 2020;26:1076029620954282. https:\/\/doi.org\/10.1177\/1076029620954282.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"8","key":"4099_CR11","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1182\/blood.2020007338","volume":"137","author":"FI Mulder","year":"2021","unstructured":"Mulder FI, Horv\u00e1th-Puh\u00f3 E, van Es N, van Laarhoven HWM, Pedersen L, Moik F, et al. Venous thromboembolism in cancer patients: a population-based cohort study. Blood. 2021;137(8):1959\u201369. https:\/\/doi.org\/10.1182\/blood.2020007338.","journal-title":"Blood"},{"issue":"15","key":"4099_CR12","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","volume":"111","author":"AA Khorana","year":"2008","unstructured":"Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood. 2008;111(15):4902\u20137. https:\/\/doi.org\/10.1182\/blood-2007-10-116327.","journal-title":"Blood"},{"issue":"Suppl 1","key":"4099_CR13","doi-asserted-by":"publisher","first-page":"S124","DOI":"10.1016\/j.thromres.2018.01.018","volume":"164","author":"M Kimpton","year":"2018","unstructured":"Kimpton M, Wells PS, Carrier M. Apixaban for the prevention of venous thromboembolism in high-risk ambulatory cancer patients receiving chemotherapy: rational and design of the AVERT trial. Thromb Res. 2018;164(Suppl 1):S124\u20139. https:\/\/doi.org\/10.1016\/j.thromres.2018.01.018.","journal-title":"Thromb Res"},{"issue":"21","key":"4099_CR14","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1056\/NEJMoa1814630","volume":"380","author":"AA Khorana","year":"2019","unstructured":"Khorana AA, Soff GA, Kakkar AK, Vadhan-Raj S, Riess H, Wun T, et al. Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer. N Engl J Med. 2019;380(21):720\u20138. https:\/\/doi.org\/10.1056\/NEJMoa1814630.","journal-title":"N Engl J Med"},{"issue":"7","key":"4099_CR15","doi-asserted-by":"publisher","first-page":"e289","DOI":"10.1016\/S2352-3026(18)30063-2","volume":"5","author":"I Pabinger","year":"2018","unstructured":"Pabinger I, van Es N, Heinze G, Posch F, Riedl J, Reitter EM, et al. A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts. Lancet Haematol. 2018;5(7):e289\u201398. https:\/\/doi.org\/10.1016\/S2352-3026(18)30063-2.","journal-title":"Lancet Haematol"},{"issue":"3","key":"4099_CR16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s11739-011-0658-6","volume":"7","author":"M Verso","year":"2012","unstructured":"Verso M, Agnelli G, Barni S, Gasparini G, La Torre F, Labianca R, et al. A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the PROTECHT score. Intern Emerg Med. 2012;7(3):291\u20136. https:\/\/doi.org\/10.1007\/s11739-011-0658-6.","journal-title":"Intern Emerg Med"},{"issue":"6","key":"4099_CR17","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.thromres.2012.07.022","volume":"130","author":"I Pabinger","year":"2012","unstructured":"Pabinger I, St\u00f6ger H, Riedl J, Faber P, Manhalter C, Quehenberger P, et al. The impact of pretherapeutic platelet count on survival and venous thromboembolism in patients with pancreatic cancer: data from the CONKO-004 trial. Thromb Res. 2012;130(6):939\u201344. https:\/\/doi.org\/10.1016\/j.thromres.2012.07.022.","journal-title":"Thromb Res"},{"issue":"3","key":"4099_CR18","doi-asserted-by":"publisher","first-page":"e163","DOI":"10.1016\/S2352-3026(23)00020-X","volume":"10","author":"A Mu\u00f1oz","year":"2023","unstructured":"Mu\u00f1oz A, Soria JM, Riedl J, Reitter EM, Pabinger I, Quehenberger P, et al. A clinical-genetic risk score for predicting cancer-associated venous thromboembolism: a development and validation study involving two independent prospective cohorts. Lancet Haematol. 2023;10(3):e163\u201372. https:\/\/doi.org\/10.1016\/S2352-3026(23)00020-X.","journal-title":"Lancet Haematol"},{"issue":"17","key":"4099_CR19","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1200\/JCO.2010.34.0984","volume":"29","author":"PL Den Exter","year":"2011","unstructured":"Den Exter PL, Hooijer J, Dekkers OM, Huisman MV. Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: a comparison with symptomatic patients. J Clin Oncol. 2011;29(17):2405\u20139. https:\/\/doi.org\/10.1200\/JCO.2010.34.0984.","journal-title":"J Clin Oncol"},{"issue":"9","key":"4099_CR20","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.3324\/haematol.2017.169060","volume":"102","author":"N Van Es","year":"2017","unstructured":"Van Es N, Di Nisio M, Cesarman G, Kleinjan A, Otten HM, Mah\u00e9 I, et al. Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study. Haematologica. 2017;102(9):1494\u2013501. https:\/\/doi.org\/10.3324\/haematol.2017.169060.","journal-title":"Haematologica"},{"issue":"8","key":"4099_CR21","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1182\/bloodadvances.2020001501","volume":"4","author":"A Qdaisat","year":"2020","unstructured":"Qdaisat A, Kamal M, Al-Breiki A, Goswami B, Wu CC, Zhou S, et al. Clinical characteristics, management, and outcome of incidental pulmonary embolism in cancer patients. Blood Adv. 2020;4(8):1606\u201314. https:\/\/doi.org\/10.1182\/bloodadvances.2020001501.","journal-title":"Blood Adv"},{"key":"4099_CR22","doi-asserted-by":"publisher","DOI":"10.1177\/10760296231212482","volume":"29","author":"Z Luo","year":"2023","unstructured":"Luo Z, Xu N, Ma G, Lu Y, Yao J, Ying K. Incidentally diagnosed with pulmonary embolism in lung cancer patients: comparison of clinical characteristics and mortality with symptomatic pulmonary embolism. Clin Appl Thromb Hemost. 2023;29:10760296231212482. https:\/\/doi.org\/10.1177\/10760296231212482.","journal-title":"Clin Appl Thromb Hemost"},{"key":"4099_CR23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.thromres.2023.12.014","volume":"234","author":"O Cohen","year":"2024","unstructured":"Cohen O, Caiano LM, Levy-Mendelovich S. Cancer-associated splanchnic vein thrombosis: clinical implications and management considerations. Thromb Res. 2024;234:75\u201385. https:\/\/doi.org\/10.1016\/j.thromres.2023.12.014.","journal-title":"Thromb Res"},{"issue":"4","key":"4099_CR24","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1055\/a-2232-5480","volume":"44","author":"S Custo","year":"2024","unstructured":"Custo S, Tabone E, Aquilina A, Gatt A, Riva N. Splanchnic vein thrombosis: the state-of-the-art on anticoagulant treatment. Hamostaseologie. 2024;44(4):242\u201354. https:\/\/doi.org\/10.1055\/a-2232-5480.","journal-title":"Hamostaseologie"},{"key":"4099_CR25","doi-asserted-by":"publisher","first-page":"117955492095309","DOI":"10.1177\/1179554920953097","volume":"14","author":"L Haggstrom","year":"2020","unstructured":"Haggstrom L, Parmar G, Brungs D. Central venous catheter thrombosis in cancer: a multi-centre retrospective study investigating risk factors and contemporary trends in management. Clin Med Insights Oncol. 2020;14:1179554920953097.","journal-title":"Clin Med Insights Oncol"},{"issue":"12","key":"4099_CR26","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1161\/01.CIR.0000142289.94369.D7","volume":"110","author":"HV Joffe","year":"2004","unstructured":"Joffe HV, Kucher N, Tapson VF, Goldhaber SZ. Upper-extremity deep vein thrombosis: a prospective registry of 592 patients. Circulation. 2004;110(12):1605\u201311.","journal-title":"Circulation"},{"issue":"7","key":"4099_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9072069","volume":"9","author":"FTM Bosch","year":"2020","unstructured":"Bosch FTM, Di Nisio M, B\u00fcller HR, van Es N. Diagnostic and therapeutic management of upper extremity deep vein thrombosis. J Clin Med. 2020;9(7):2069.","journal-title":"J Clin Med"},{"issue":"1","key":"4099_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11010095","volume":"11","author":"S Riondino","year":"2019","unstructured":"Riondino S, Ferroni P, Zanzotto FM, Roselli M, Guadagni F. Predicting VTE in cancer patients: candidate biomarkers and risk assessment models. Cancers (Basel). 2019;11(1):95. https:\/\/doi.org\/10.3390\/cancers11010095.","journal-title":"Cancers (Basel)"},{"issue":"15","key":"4099_CR29","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.1002\/cncr.26597","volume":"118","author":"M Dutia","year":"2012","unstructured":"Dutia M, White RH, Wun T. Risk assessment models for cancer-associated venous thromboembolism. Cancer. 2012;118(15):3468\u201376. https:\/\/doi.org\/10.1002\/cncr.26597.","journal-title":"Cancer"},{"issue":"Suppl 1","key":"4099_CR30","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/S0049-3848(20)30392-0","volume":"191","author":"F Posch","year":"2020","unstructured":"Posch F, Ay C. The impact of clinical prediction models for cancer-associated venous thromboembolism. Thromb Res. 2020;191(Suppl 1):S41\u20137. https:\/\/doi.org\/10.1016\/S0049-3848(20)30392-0.","journal-title":"Thromb Res"},{"issue":"9382","key":"4099_CR31","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S0140-6736(03)14198-4","volume":"362","author":"CY Vossen","year":"2003","unstructured":"Vossen CY, Conard J, Fontcuberta J, Makris M, Palareti G, Pabinger I, et al. Risk of a first venous thrombotic event in carriers of a prothrombotic mutation and effect of oral contraceptives: a meta-analysis. Lancet. 2003;362(9382):523\u201330. https:\/\/doi.org\/10.1016\/S0140-6736(03)14198-4.","journal-title":"Lancet"},{"issue":"10","key":"4099_CR32","doi-asserted-by":"publisher","first-page":"e14060","DOI":"10.1111\/eci.14060","volume":"53","author":"J Gotta","year":"2023","unstructured":"Gotta J, Gruenewald LD, Eichler K, Martin SS, Mahmoudi S, Booz C, et al. Unveiling the diagnostic enigma of D-dimer testing in cancer patients: current evidence and areas of application. Eur J Clin Invest. 2023;53(10):e14060. https:\/\/doi.org\/10.1111\/eci.14060.","journal-title":"Eur J Clin Invest"},{"issue":"5","key":"4099_CR33","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1111\/jth.15260","volume":"19","author":"F Posch","year":"2021","unstructured":"Posch F, Riedl J, Reitter EM, Kaider A, Zielinski C, Pabinger I, et al. Hypercoagulability as a prognostic factor for cancer patients receiving immune checkpoint inhibitors: the Vienna cancer and thrombosis study. J Thromb Haemost. 2021;19(5):1170\u201380. https:\/\/doi.org\/10.1111\/jth.15260.","journal-title":"J Thromb Haemost"},{"issue":"8","key":"4099_CR34","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.3324\/haematol.2011.054718","volume":"97","author":"C Ay","year":"2012","unstructured":"Ay C, Dunkler D, Pirker R, Thaler J, Quehenberger P, Schillinger M, et al. High D-dimer levels are associated with poor prognosis in cancer patients. Haematologica. 2012;97(8):1158\u201364. https:\/\/doi.org\/10.3324\/haematol.2011.054718.","journal-title":"Haematologica"},{"key":"4099_CR35","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.thromres.2019.08.004","volume":"182","author":"M Alexander","year":"2019","unstructured":"Alexander M, Solomon B, Ball DL, MacManus MP, Walpole ET, Black K, et al. Risk prediction of venous thromboembolism in patients with lung cancer: a cohort study using a risk assessment model derived from a large population-based cohort. Thromb Res. 2019;182:58\u201364. https:\/\/doi.org\/10.1016\/j.thromres.2019.08.004.","journal-title":"Thromb Res"},{"issue":"36","key":"4099_CR36","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.1200\/JCO.21.01542","volume":"39","author":"A Li","year":"2021","unstructured":"Li A, Garcia DA, Lyman GH, Noble S, Khorana AA. Development and validation of a risk assessment model for immunothrombosis in hospitalized patients with cancer. J Clin Oncol. 2021;39(36):4020\u201331. https:\/\/doi.org\/10.1200\/JCO.21.01542.","journal-title":"J Clin Oncol"},{"issue":"11","key":"4099_CR37","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1055\/s-0039-1696676","volume":"119","author":"A Carmona-Bayonas","year":"2019","unstructured":"Carmona-Bayonas A, Jim\u00e9nez-Fonseca P, Casta\u00f1\u00f3n \u00c1, Font C, Navarro V, Beato C, et al. Prediction of venous thromboembolism in ambulatory cancer patients. development of the ONKOTIC nomogram and external validation. Thromb Haemost. 2019;119(11):1900\u20139. https:\/\/doi.org\/10.1055\/s-0039-1696676.","journal-title":"Thromb Haemost"},{"key":"4099_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100708","volume":"44","author":"S Tavora","year":"2021","unstructured":"Tavora S, Zangari M, Palumbo A. Changing patterns of thrombotic risk in cancer: Insights into the role of thrombosis in the pathophysiology of cancer. Blood Rev. 2021;44:100708. https:\/\/doi.org\/10.1016\/j.blre.2020.100708.","journal-title":"Blood Rev"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-04099-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-025-04099-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-04099-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T05:14:32Z","timestamp":1774415672000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-025-04099-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,26]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["4099"],"URL":"https:\/\/doi.org\/10.1007\/s12094-025-04099-2","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,26]]},"assertion":[{"value":"27 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Irene Gonz\u00e1lez Caraballo: Travel, accommodations, expenses: MSD, Rovi, Gilead, Rizmoic. Andr\u00e9s Jes\u00fas Mu\u00f1oz Mart\u00edn: consultant or advisory role: GSK, Pfizer, BMS-Celgene, Sanofi, Astra-Zeneca, MSD, Lilly, Servier, Roche, Taiho, Leo Pharma, Regeneron. Research funding: Leo Pharma, Sanofi, BMS-Celgene. Speakers\u2019 bureau: Rovi, Menarini, Stada, Medscape. Patents, royalties, other intellectual property: risk assessment model in venous thromboembolism in cancer patients. Liquid biopsy developed with laser technology. The rest of the authors declare no conflicts of interest for the present article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}